Core Insights - The company, Lingrui Pharmaceutical, has established itself as a household name in the production of medicated plasters, leveraging advanced technology and innovation to enhance product quality and production efficiency [1][2][3] Group 1: Production and Technology - Lingrui Pharmaceutical has implemented smart manufacturing systems, including a digital extraction process that ensures the quality stability of traditional Chinese medicine extracts [1] - The company has developed an integrated ERP data platform that connects sales, production, and inventory data, allowing for real-time intelligent production scheduling and energy-efficient operations [2] - The production facility is capable of producing 10,000 medicated plasters per minute, showcasing the efficiency of its smart manufacturing processes [1] Group 2: Product Development and Market Position - The company has expanded its product line through continuous research and development, with its "Two Tigers" medicated plaster series achieving annual sales exceeding 1 billion plasters [3] - Lingrui Pharmaceutical is set to launch a new innovative drug, a nasal spray for treating cold symptoms, which will broaden its therapeutic offerings and enhance clinical value [3] - The company invests 3% to 5% of its annual revenue into research and development, establishing high-level platforms such as a national enterprise technology center and a postdoctoral research workstation [3]